[RGLS] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
01-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 7.45%
YoY- -50.15%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 18 18 18 204 1,865 1,083 6,118 -62.12%
PBT -5,423 -10,273 -15,835 -19,515 -13,016 -9,798 -2,169 16.49%
Tax 87 201 -7 4 -16 -2,259 -5 -
NP -5,423 -10,273 -15,828 -19,519 -13,000 -9,798 -2,164 16.53%
Tax Rate - - - - - - - -
Total Cost 5,441 10,291 15,846 19,723 14,865 10,881 8,282 -6.75%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -30,127.78 -57,072.22 -87,933.33 -9,568.14 -697.05 -904.71 -35.37 207.72%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -2.60 -11.80 -21.09 -44.33 -30.01 -27.09 -6.47 -14.09%
EPS Diluted -2.60 -11.80 -21.09 -44.33 -30.01 -26.21 -6.25 -13.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.